LUCYW (LUCYW) Stock Price & Analysis
LUCYW (LUCYW) closed at USD 0.03 on Tuesday, October 13, 2026, up 0.00% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 0.03; the Oct 13, 2026 session ranged USD 0.03–0.03 on volume of 4 shares. Market capitalization is —, with a 52-week range of USD 0.03–0.15 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:51 UTC.
Also available as compact Markdown for AI agents: nexqual.com/LUCYW.md
Key facts (LUCYW)
- Analysts: None.
- Total return with dividends: 1Y -71.1% vs S&P 500 +18.1%; 5Y -96.0% vs S&P 500 +85.1%.
Analysts (LUCYW)
Consensus None.
Total return (dividends reinvested) (LUCYW)
| 1Y (from 2025-10-16) | 5Y (from 2022-08-15) | |
|---|---|---|
| Total return | -71.1% | -96.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -71.3% | -53.8% |
| Volatility (annualized) | 236.4% | 216.8% |
| Max drawdown | -79.2% (Oct 2025→Jun 2026) | -96.5% (Sep 2022→Oct 2026) |
Key Statistics (as of October 16, 2026 at 05:51 UTC)
| Price | USD 0.03 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.03 |
| Open | USD 0.03 |
| Day Range | USD 0.03 – 0.03 |
| 52-Week Range | USD 0.03 – 0.15 |
| Volume | 4 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (LUCYW)
Nexqual's technical model rates LUCYW "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:51 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.63 (neutral) |
| vs SMA50 | Below (USD 0.04) |
| MACD | -0 (negative) |
Analyst Ratings (LUCYW)
Wall Street analysts rate LUCYW "None", per Nexqual as of October 16, 2026 at 05:51 UTC.
| Consensus Rating | None |
|---|
Financial Health Score (LUCYW)
Nexqual rates LUCYW's overall financial health "Weak" across five dimensions, as of October 16, 2026 at 05:51 UTC.
| Growth | Strong — Revenue +63% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $4M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$7M (TTM) |
| Efficiency | Critical — ROE -85%, ROA -54.7% |
Leadership (LUCYW)
LUCYW is led by Harrison Reed Gross (age 32), Co-Founder, CEO & Director, per Nexqual as of October 16, 2026 at 05:51 UTC.
| Co-Founder, CEO & Director | Harrison Reed Gross (age 32) |
|---|---|
| Co-Founder & CTO | David Eric Cohen (age 52) |
| Chief Financial Officer | Oswald Anthony Gayle (age 65) |
| Chief Operating Officer | Jaoquin Abondano (age 41) |
Major Backers & Investors (LUCYW)
Notable institutional backers of LUCYW include Clear Street Group Inc., Brave Asset Management Inc., Citadel, according to Nexqual as of October 16, 2026 at 05:51 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Clear Street Group Inc. | 5.76% |
| Brave Asset Management Inc. | 1.57% |
| Citadel | 1.41% |
Source: Nexqual, October 16, 2026 at 05:51 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SKYAW | SkyAI, Inc. | USD 0.06 | ▼ 4.59% |
| LUCY | Innovative Eyewear, Inc. | USD 0.84 | ▼ 1.12% |
| BIAFW | bioAffinity Technologies, Inc. | USD 0.3 | ▲ 0% |
| NRSNW | NEUROSENSE THERAPEUTICS LTD C/W | USD 0.01 | ▲ 1.94% |
| KTTAW | Pasithea Therapeutics Corp. Warrant | USD 0 | ▲ 0% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:51 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt